Immune response to GeneVac-B^Ⓡ (rDNA I.P. hepatitis B vaccine) in vaccinated persons with a standard schedule in Bobo-Dioulasso, Burkina Faso.

ABSTRACT:

Objective

This study aimed to evaluate the immune response in people fully vaccinated against hepatitis B with the GeneVac-B^Ⓡ vaccine in Burkina Faso under actual conditions of use.

Methods

This cross-sectional study included individuals fully vaccinated with GeneVac-B^Ⓡ. For each consenting participant, sociodemographic and clinical data were collected using a structured questionnaire. Approximately 4 ml of whole blood was collected for immunological (anti-HBs, hepatitis B surface antigen, anti-hepatitis C virus, and anti-HIV) and biochemical (blood glucose, total cholesterol, and triglycerides) testing. The anti-HBs titer was used to determine the immune response.

Results

A total of 392 participants were included in the study. The mean age was 3

SUBMITTER: Ouattara NGM 

PROVIDER: S-EPMC11618024 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature